A multi-scale approach to designing therapeutics for tuberculosis.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Integrative Biology

• Publication date

  2015-05-11

• Fields of study

  Medicine

• Identifiers
  DOI 10.1039/c4ib00295dPMID 25924949PMCID PMC4436084
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mass spectrometry imaging of levofloxacin distribution in TB-infected pulmonary lesions by MALDI-MSI and continuous liquid microjunction surface sampling.

  2015cited by this paper
• In silico models of M. tuberculosis infection provide a route to new therapies.

  2015cited by this paper
• Computational Modeling Predicts IL-10 Control of Lesion Sterilization by Balancing Early Host Immunity–Mediated Antimicrobial Responses with Caseation during Mycobacterium tuberculosis Infection

  2015cited by this paper
• A computational tool integrating host immunity with antibiotic dynamics to study tuberculosis treatment.

  2015cited by this paper
• Systems Pharmacology Approach Toward the Design of Inhaled Formulations of Rifampicin and Isoniazid for Treatment of Tuberculosis

  2015cited by this paper
• Exploring the collaboration between antibiotics and the immune response in the treatment of acute, self-limiting infections

  2014cited by this paper
• Tuneable resolution as a systems biology approach for multi-scale, multi-compartment computational models

  2014cited by this paper
• Tuberculosis vaccines--rethinking the current paradigm.

  2014cited by this paper
• Harnessing the Heterogeneity of T Cell Differentiation Fate to Fine-Tune Generation of Effector and Memory T Cells

  2014cited by this paper
• Strategies for Efficient Numerical Implementation of Hybrid Multi-scale Agent-Based Models to Describe Biological Systems

  2014cited by this paper
• Analysis of Combination Drug Therapy to Develop Regimens with Shortened Duration of Treatment for Tuberculosis

  2014cited by this paper
• Microfluidic source-sink model reveals effects of biophysically distinct CXCL12 isoforms in breast cancer chemotaxis.

  2014cited by this paper
• Sterilization of granulomas is common in both active and latent tuberculosis despite extensive within-host variability in bacterial killing

  2014cited by this paper
• Vaccine against tuberculosis: what’s new?

  2014cited by this paper
• Macrophage Polarization Drives Granuloma Outcome during Mycobacterium tuberculosis Infection

  2014cited by this paper
• Recent advances towards tuberculosis control: vaccines and biomarkers

  2014cited by this paper
• A model of isoniazid treatment of tuberculosis.

  2014cited by this paper
• The path of anti-tuberculosis drugs: from blood to lesions to mycobacterial cells

  2014cited by this paper
• Tuberculosis vaccines: time to think about the next generation.

  2013cited by this paper
• Radiologic Responses in Cynomolgus Macaques for Assessing Tuberculosis Chemotherapy Regimens

  2013cited by this paper
• Advances in the development of new tuberculosis drugs and treatment regimens

  2013cited by this paper
• A Physiologically Based Pharmacokinetic Model of Rifampin in Mice

  2013cited by this paper
• Mining large-scale response networks reveals ‘topmost activities’ in Mycobacterium tuberculosis infection

  2013cited by this paper
• The Mycobacterium tuberculosis regulatory network and hypoxia

  2013cited by this paper
• Probing Gene Regulatory Networks to Decipher Host–Pathogen Interactions

  2013cited by this paper
• The mutation rate of mycobacterial repetitive unit loci in strains of M. tuberculosis from cynomolgus macaque infection

  2013cited by this paper
• TB or Not TB: That Is No Longer the Question

  2013cited by this paper
• Predicting lymph node output efficiency using systems biology.

  2013cited by this paper
• The immune response in tuberculosis.

  2013cited by this paper
• Microenvironments in Tuberculous Granulomas Are Delineated by Distinct Populations of Macrophage Subsets and Expression of Nitric Oxide Synthase and Arginase Isoforms

  2013cited by this paper
• The Roles of Immune Memory and Aging in Protective Immunity and Endogenous Reactivation of Tuberculosis

  2013cited by this paper
• Updating and curating metabolic pathways of TB.

  2013cited by this paper
• 13C-Flux Spectral Analysis of Host-Pathogen Metabolism Reveals a Mixed Diet for Intracellular Mycobacterium tuberculosis

  2013cited by this paper
• Multi-Scale Modeling Predicts a Balance of Tumor Necrosis Factor-α and Interleukin-10 Controls the Granuloma Environment during Mycobacterium tuberculosis Infection

  2013cited by this paper
• Mechanistic systems modeling to guide drug discovery and development.

  2013cited by this paper
• A Systems Biology Approach for Understanding Granuloma Formation and Function in Tuberculosis

  2013cited by this paper
• Sterilization of granulomas is common in both active and latent tuberculosis despite extensive within-host variability in bacterial killing

  2013cited by this paper
• A metabolic network approach for the identification and prioritization of antimicrobial drug targets.

  2012cited by this paper
• Cytokine Response Is Determined by Duration of Receptor and Signal Transducers and Activators of Transcription 3 (STAT3) Activation*

  2012cited by this paper
• SOCS3 Deficiency Promotes M1 Macrophage Polarization and Inflammation

  2012cited by this paper
• Revisiting the role of the granuloma in tuberculosis

  2012cited by this paper
• Metronidazole prevents reactivation of latent Mycobacterium tuberculosis infection in macaques

  2012cited by this paper
• NF-κB Signaling Dynamics Play a Key Role in Infection Control in Tuberculosis

  2012cited by this paper
• Differential Risk of Tuberculosis Reactivation among Anti-TNF Therapies Is Due to Drug Binding Kinetics and Permeability

  2012cited by this paper
• The multistage vaccine H56 boosts the effects of BCG to protect cynomolgus macaques against active tuberculosis and reactivation of latent Mycobacterium tuberculosis infection.

  2012cited by this paper
• Metabolic network analysis predicts efficacy of FDA-approved drugs targeting the causative agent of a neglected tropical disease

  2012cited by this paper
• Targeting Persisters for Tuberculosis Control

  2012cited by this paper
• Mycobacterium tuberculosis inhibits neutrophil apoptosis, leading to delayed activation of naive CD4 T cells.

  2012cited by this paper
• A hybrid multi-compartment model of granuloma formation and T cell priming in tuberculosis.

  2011cited by this paper
• Latent tuberculosis: what the host “sees”?

  2011cited by this paper
• 13C Metabolic Flux Analysis Identifies an Unusual Route for Pyruvate Dissimilation in Mycobacteria which Requires Isocitrate Lyase and Carbon Dioxide Fixation

  2011cited by this paper
• Variability in the population pharmacokinetics of isoniazid in South African tuberculosis patients.

  2011cited by this paper
• A Physiologically Based Pharmacokinetic Model for Capreomycin

  2011cited by this paper
• Pharmacokinetic Evaluation of the Penetration of Antituberculosis Agents in Rabbit Pulmonary Lesions

  2011cited by this paper
• A multifaceted approach to modeling the immune response in tuberculosis

  2011cited by this paper
• Multiscale Computational Modeling Reveals a Critical Role for TNF-α Receptor 1 Dynamics in Tuberculosis Granuloma Formation

  2011cited by this paper
• The role of IL-10 in immune regulation during M. tuberculosis infection

  2011cited by this paper
• A multistage tuberculosis vaccine that confers efficient protection before and after exposure

  2011cited by this paper
• Population pharmacokinetics and its role in anti-tuberculosis drug development and optimization of treatment.

  2011cited by this paper
• High-sensitivity MALDI-MRM-MS imaging of moxifloxacin distribution in tuberculosis-infected rabbit lungs and granulomatous lesions.

  2011cited by this paper
• Inhaled drug therapy for treatment of tuberculosis.

  2011cited by this paper
• Mathematical modeling of pulmonary tuberculosis therapy: Insights from a prototype model with rifampin.

  2011cited by this paper
• Regulation and functions of the IL-10 family of cytokines in inflammation and disease.

  2011cited by this paper
• Nanobead-based interventions for the treatment and prevention of tuberculosis

  2010cited by this paper
• Tumor necrosis factor neutralization results in disseminated disease in acute and latent Mycobacterium tuberculosis infection with normal granuloma structure in a cynomolgus macaque model.

  2010cited by this paper
• Time-kill kinetics of anti-tuberculosis drugs, and emergence of resistance, in relation to metabolic activity of Mycobacterium tuberculosis.

  2010cited by this paper
• Treatment of tuberculosis and optimal dosing schedules

  2010cited by this paper
• Single-cell NF-κB dynamics reveal digital activation and analogue information processing

  2010cited by this paper
• A systems perspective of host-pathogen interactions: predicting disease outcome in tuberculosis.

  2010cited by this paper
• In Silico Children and the Glass Mouse Model: Clinical Trial Simulations To Identify and Individualize Optimal Isoniazid Doses in Children with Tuberculosis

  2010cited by this paper
• TNF and IL-10 are major factors in modulation of the phagocytic cell environment in lung and lymph node in tuberculosis: a next-generation two-compartmental model.

  2010cited by this paper
• Characterizing the Dynamics of CD4+ T Cell Priming within a Lymph Node

  2010cited by this paper
• Identification of Key Processes that Control Tumor Necrosis Factor Availability in a Tuberculosis Granuloma

  2010cited by this paper
• Understanding Latent Tuberculosis: A Moving Target

  2010cited by this paper
• The potent bactericidal activity of streptomycin in the guinea pig model of tuberculosis ceases due to the presence of persisters.

  2010cited by this paper
• New old challenges in tuberculosis: potentially effective nanotechnologies in drug delivery.

  2010cited by this paper
• A modeling analysis of the effects of molecular size and binding affinity on tumor targeting

  2009cited by this paper
• Population Modeling and Monte Carlo Simulation Study of the Pharmacokinetics and Antituberculosis Pharmacodynamics of Rifampin in Lungs

  2009cited by this paper
• A simple in vitro PK/PD model system to determine time-kill curves of drugs against Mycobacteria.

  2009cited by this paper
• Synergy between Individual TNF-Dependent Functions Determines Granuloma Performance for Controlling Mycobacterium tuberculosis Infection1

  2009cited by this paper
• Inhaled Drug Delivery for Tuberculosis Therapy

  2009cited by this paper
• The role of the granuloma in expansion and dissemination of early tuberculous infection.

  2009cited by this paper
• Advances in immunotherapy for tuberculosis treatment.

  2009cited by this paper
• Quantitative Comparison of Active and Latent Tuberculosis in the Cynomolgus Macaque Model

  2009cited by this paper
• The spectrum of latent tuberculosis: rethinking the biology and intervention strategies

  2009cited by this paper
• Lack of IL-10 alters inflammatory and immune responses during pulmonary Mycobacterium tuberculosis infection.

  2009cited by this paper
• Population Pharmacokinetics of Rifampin in Pulmonary Tuberculosis Patients, Including a Semimechanistic Model To Describe Variable Absorption

  2008cited by this paper
• Tumor necrosis factor blockers influence macrophage responses to Mycobacterium tuberculosis.

  2008cited by this paper
• Tumor Necrosis Factor Blockade in Chronic Murine Tuberculosis Enhances Granulomatous Inflammation and Disorganizes Granulomas in the Lungs

  2008cited by this paper
• A methodology for performing global uncertainty and sensitivity analysis in systems biology.

  2008cited by this paper
• Mathematical modeling of drug delivery.

  2008cited by this paper
• Tuberculous Granulomas Are Hypoxic in Guinea Pigs, Rabbits, and Nonhuman Primates

  2008cited by this paper
• Prediction of Tumour Tissue Diffusion Coefficients of Hypoxia-Activated Prodrugs from Physicochemical Parameters

  2008cited by this paper
• Modelling the effects of pre-exposure and post-exposure vaccines in tuberculosis control.

  2008cited by this paper
• Investigating the metabolic capabilities of Mycobacterium tuberculosis H37Rv using the in silico strain iNJ661 and proposing alternative drug targets

  2007cited by this paper
• Differences in Reactivation of Tuberculosis Induced from Anti-TNF Treatments Are Based on Bioavailability in Granulomatous Tissue

  2007cited by this paper
• Isoniazid Bactericidal Activity and Resistance Emergence: Integrating Pharmacodynamics and Pharmacogenomics To Predict Efficacy in Different Ethnic Populations

  2007cited by this paper
• Immunotherapeutics for tuberculosis in experimental animals: is there a common pathway activated by effective protocols?

  2007cited by this paper
• Implementation of a transit compartment model for describing drug absorption in pharmacokinetic studies

  2007cited by this paper
• Why Is Long-Term Therapy Required to Cure Tuberculosis?

  2007cited by this paper

• Targeting ALOX5/LTA4H driven granuloma caseation as a host-directed strategy for control of TB associated lung damage

  2025cites this paper
• Perceived risk induced multiscale model: Coupled within-host and between-host dynamics and behavioral dynamics.

  2024cites this paper
• Characterizing the immune response to Mycobacterium tuberculosis: a comprehensive narrative review and implications in disease relapse

  2024cites this paper
• In Silico Studies to Support Vaccine Development

  2023cites this paper
• Perspectives on in silico bone mechanobiology: computational modelling of multicellular systems.

  2022cites this paper
• Simulations of tumor growth and response to immunotherapy by coupling a spatial agent-based model with a whole-patient quantitative systems pharmacology model

  2022influential citation
• Both Pharmacokinetic Variability and Granuloma Heterogeneity Impact the Ability of the First-Line Antibiotics to Sterilize Tuberculosis Granulomas

  2020cites this paper
• Review of Mathematical Modeling of the Inflammatory Response in Lung Infections and Injuries

  2020cites this paper
• In Vitro Granuloma Models of Tuberculosis: Potential and Challenges.

  2019cites this paper
• A computational model tracks whole-lung Mycobacterium tuberculosis infection and predicts factors that inhibit dissemination

  2019cites this paper
• The Spectrum of Mechanism-Oriented Models and Methods for Explanations of Biological Phenomena

  2018cites this paper
• Review of the systems biology of the immune system using agent-based models.

  2018cites this paper
• The Spectrum of Mechanism-oriented Models for Explanations of Biological Phenomena

  2018cites this paper
• Model Systems for Pulmonary Infectious Diseases: Paradigms of Anthrax and Tuberculosis.

  2017cites this paper
• A review of computational and mathematical modeling contributions to our understanding of Mycobacterium tuberculosis within-host infection and treatment.

  2017cites this paper
• Applying Optimization Algorithms to Tuberculosis Antibiotic Treatment Regimens

  2017cites this paper
• A complete categorization of multiscale models of infectious disease systems

  2017cites this paper
• Drug delivery for tuberculosis: is inhaled therapy the key to success?

  2017cites this paper
• Applying Optimization Algorithms to Tuberculosis Antibiotic Treatment Regimens

  2017cites this paper
• Modelling human immune response dynamics to Mycobacterium Tuberculosis infection.

  2017cites this paper
• Strategic Priming with Multiple Antigens can Yield Memory Cell Phenotypes Optimized for Infection with Mycobacterium tuberculosis: A Computational Study

  2016influential citation
• Computational immuno-biology for organ transplantation and regenerative medicine.

  2016cites this paper
• Mathematical Models for Immunology: Current State of the Art and Future Research Directions

  2016cites this paper
• Facing the challenges of multiscale modelling of bacterial and fungal pathogen–host interactions

  2016cites this paper
• First airborne pathogen direct analysis system.

  2016cites this paper
• Genetic variants in Alzheimer disease — molecular and brain network approaches

  2016cites this paper
• Local Inflammation, Dissemination and Coalescence of Lesions Are Key for the Progression toward Active Tuberculosis: The Bubble Model

  2016cites this paper
• Modeling Granulomas in Response to Infection in the Lung

  2016cites this paper
• Predictive Model of Lymphocyte-Specific Protein Tyrosine Kinase (LCK) Autoregulation

  2016cites this paper
• Multi-class and multi-scale models of complex biological phenomena.

  2016cites this paper
• Quantifying the Generation of T Cell Immunity using a Systems Biology Approach.

  2015cites this paper
• Multi-class and Multi-scale Models of Complex Biological Phenomena This Review Comes from a Themed Issue on Systems Biology Sciencedirect Classes and Scales of Computational Models Model Classification Molecular Protein Network Cellular

  year unknowncites this paper